Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetRevenue - OtherRevenue - RentalShares IssuedShares OutstandingShares OutstandingWages, Salaries and Other
Ratios

Maxcyte (MXCT) Accumulated Depreciation & Amortization (2020 - 2026)

Maxcyte has reported Accumulated Depreciation & Amortization over the past 6 years, most recently at -$15.6 million for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 11.83% to -$15.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$15.6 million through Dec 2025, up 11.83% year-over-year, with the annual reading at -$15.6 million for FY2025, 11.83% up from the prior year.
  • Accumulated Depreciation & Amortization was -$15.6 million for Q4 2025 at Maxcyte, down from -$3.8 million in the prior quarter.
  • Over five years, Accumulated Depreciation & Amortization peaked at -$3.5 million in Q2 2021 and troughed at -$24.9 million in Q1 2023.
  • The 5-year median for Accumulated Depreciation & Amortization is -$8.8 million (2022), against an average of -$10.7 million.
  • Year-over-year, Accumulated Depreciation & Amortization plummeted 305.07% in 2022 and then skyrocketed 68.72% in 2024.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at -$5.6 million in 2021, then plummeted by 155.76% to -$14.2 million in 2022, then skyrocketed by 37.65% to -$8.9 million in 2023, then plummeted by 99.82% to -$17.7 million in 2024, then grew by 11.83% to -$15.6 million in 2025.
  • Per Business Quant, the three most recent readings for MXCT's Accumulated Depreciation & Amortization are -$15.6 million (Q4 2025), -$3.8 million (Q3 2025), and -$4.6 million (Q2 2025).